Division of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden.
Oral Dis. 2010 Oct;16(7):661-7. doi: 10.1111/j.1601-0825.2010.01672.x.
To define the influence of cholecystokinin and melatonin on the inflammatory response of the lipopolysaccharide-exposed rat parotid gland.
Bacterial lipopolysaccharide was infused retrogradely into the parotid duct. The degree of inflammation three hours postadministration was estimated from the activity of myeloperoxidase, reflecting glandular neutrophil infiltration.
The myeloperoxidase activity of the lipopolysaccharide-exposed gland was 10-fold greater than that of the contralateral gland. Combined with sulphated cholecystokinin-8 (10 or 25 μg kg(-1) , given twice intraperitoneally) or melatonin (10 or 25 mg kg(-1) x 2) the lipopolysaccharide-induced response was elevated 4.6- and 3.5-folds at the most. The cholecystokinin-A receptor antagonist lorglumide reduced the inhibitory effect of cholecystokinin-8, while the melatonin 2-preferring receptor antagonist luzindole had no effect on the melatonin-induced inhibition. Unselective nitric oxide-synthase inhibition abolished the increase in myeloperoxidase activity, whereas inhibition of inducible or neuronal nitric oxide-synthase (of non-nervous origin) halved the inflammatory response.
Some hormones may contribute to anti-inflammatory action in salivary glands in physiological conditions. They are potential pharmacological tools for treating gland inflammation. The inflammation, as judged from the myeloperoxidase activity, was entirely dependent on nitric oxide-synthase activity, indicating that the hormones directly or indirectly reduced the generation of nitric oxide.
确定胆囊收缩素和褪黑素对脂多糖暴露大鼠腮腺炎症反应的影响。
将细菌脂多糖逆行注入腮腺导管。给药后 3 小时,通过髓过氧化物酶活性评估炎症程度,反映腺体中性粒细胞浸润。
脂多糖暴露的腺体髓过氧化物酶活性比对侧腺体高 10 倍。与硫酸化胆囊收缩素-8(10 或 25μgkg(-1),腹腔内给药 2 次)或褪黑素(10 或 25mgkg(-1)x2)联合使用时,脂多糖诱导的反应最高可升高 4.6 倍和 3.5 倍。胆囊收缩素 A 受体拮抗剂 lorglumide 降低了胆囊收缩素-8 的抑制作用,而褪黑素 2 型受体拮抗剂 luzindole 对褪黑素诱导的抑制作用没有影响。非选择性一氧化氮合酶抑制剂消除了髓过氧化物酶活性的增加,而诱导型或神经元型一氧化氮合酶(非神经来源)的抑制使炎症反应减半。
某些激素可能有助于在生理条件下发挥唾液腺的抗炎作用。它们是治疗腺体炎症的潜在药理学工具。从髓过氧化物酶活性判断,炎症完全依赖于一氧化氮合酶活性,表明这些激素直接或间接减少了一氧化氮的产生。